Histone deacetylase inhibitors promote osteoblast maturation.
about
Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studiesHistone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent mannerEpigenetic Mechanisms in Bone Biology and Osteoporosis: Can They Drive Therapeutic Choices?Nothing Boring About BoronHistone deacetylase 3 depletion in osteo/chondroprogenitor cells decreases bone density and increases marrow fatRegulation of gene expression in osteoblasts.Runx2- and histone deacetylase 3-mediated repression is relieved in differentiating human osteoblast cells to allow high bone sialoprotein expressionHistone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcriptionThe epigenetic paradigm in periodontitis pathogenesis.Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors.miR-365 Ameliorates Dexamethasone-Induced Suppression of Osteogenesis in MC3T3-E1 Cells by Targeting HDAC4.Dipeptidyl Peptidase-4 and Adolescent Idiopathic Scoliosis: Expression in Osteoblasts.Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice.Metastatic bone disease: role of transcription factors and future targets.Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cellsEpigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment.Histone deacetylases in skeletal development and bone mass maintenance.The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone lossSuberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.In Vitro and In Vivo Osteogenic Activity of Largazole.(+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activationHDAC9 Inhibits Osteoclastogenesis via Mutual Suppression of PPARγ/RANKL Signaling.Hdac-mediated control of endochondral and intramembranous ossificationEpigenetic Library Screen Identifies Abexinostat as Novel Regulator of Adipocytic and Osteoblastic Differentiation of Human Skeletal (Mesenchymal) Stem CellsSignaling networks that control the lineage commitment and differentiation of bone cells.Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression.A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcomaDental pulp stem cells. Biology and use for periodontal tissue engineering.Exposure to valproic acid inhibits chondrogenesis and osteogenesis in mid-organogenesis mouse limbs.MDM2 E3 ligase-mediated ubiquitination and degradation of HDAC1 in vascular calcification.Signaling and transcriptional regulation in osteoblast commitment and differentiationEpigenetic Mechanisms Regulating Mesenchymal Stem Cell Differentiation.Runx2 protein represses Axin2 expression in osteoblasts and is required for craniosynostosis in Axin2-deficient miceKinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-κB pathways.Antiepileptic drug use and rates of hip bone loss in older men: a prospective study.Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation.Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.
P2860
Q24289320-99B6FE92-42D8-4020-AF77-3FD50B7F6A0BQ24300259-806AAD41-6177-4E49-8DD0-4E59BE00162CQ26741198-B5E7B08A-1B5E-4145-BC0E-CDD73937D609Q26771927-635A43C8-B12F-479D-9884-AEE72AFC5C59Q27324052-7AF86F08-7B40-4F93-BAA6-EA26F476EB60Q27691363-A430BFA2-6F4C-4674-981A-01311F4CA580Q28254466-8A44250B-EE7A-43EA-8B20-C50D63039199Q28505369-3088129D-6CBF-4FED-BEAC-1EE7241D26E0Q30375023-EF54AF7E-0DCE-4E76-8827-29892D919AA1Q33290977-BF1871E9-3EF9-48C5-9D0A-01551480C4D2Q33302058-BA28C687-ACA3-41D3-ADEE-152180DE10C0Q33755006-5AC4D626-9218-4E46-AAE7-75DFB831CBC9Q33784648-171B2709-B7DB-416B-89EA-DB70AD5681AEQ34016769-0F5833D8-2C70-4D81-BD29-FD630C5D3189Q34217531-73508F33-0111-43FB-8FFB-BA4C3F90C4DFQ34408710-BA41A3B2-577D-4281-B2BB-D5C7FBD896E1Q34475885-390854D9-FC76-4158-80C9-7E23108D2249Q34496410-7179F69A-7FAA-4E54-80EF-24947A608C15Q34575607-B14658AE-6E96-4F98-8BEC-27DACF6CC328Q34612849-E6DE5554-EC28-48E8-B736-7AF5E3C9FC27Q34686787-8D6F3D54-1DA2-44E8-8B71-4853544A24C7Q34810920-406F716C-DBDD-492A-AB50-D1BF714D7603Q35030533-2211CC34-7639-451D-9F9D-DFC657A34005Q35099825-33C0EFB7-1AD2-4B8D-98D9-F6A8D5754E50Q35555670-F793D1CF-3A08-4AAD-B040-4C72A63EC8D8Q35556841-09A3193C-250F-47D6-ADAF-251FCEE6F76AQ36021958-1716B850-C702-443E-A66E-5AF63FD3EF80Q36082866-5DAB75D9-0886-4CB5-B566-FFD78840E217Q36181298-CEF5D394-0BEB-47BE-92EB-64DED2D7439EQ36342282-73E173F1-7163-4FDB-B0BA-5291BC102B63Q36448603-64D71AB6-F307-4BC3-811F-F3237729F1F6Q36509064-A5F1B9DC-EB5F-4D90-B3A4-7AC3EEB6BCE7Q36541232-3682C051-7D4C-4F3A-ABD0-A6B5B6B15BBCQ36606452-41431A92-BCCC-4712-92CC-A1E4D2AF60E8Q36613056-E8043B28-5830-451C-8022-9B4F3494CDB2Q36635990-05A4D4B5-681B-4C7E-828F-30C113BE73AAQ36770410-728D897A-AB8E-454A-84C9-3A321168727FQ37178973-D0C05B54-2A6A-45C3-8CA0-BB659881DB99Q37213816-8EA9F266-4394-4FDC-87B1-7A33EAF5F1E5Q37335897-ADD27281-831D-49F1-AFBC-EDCB9829B1B4
P2860
Histone deacetylase inhibitors promote osteoblast maturation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Histone deacetylase inhibitors promote osteoblast maturation.
@ast
Histone deacetylase inhibitors promote osteoblast maturation.
@en
Histone deacetylase inhibitors promote osteoblast maturation.
@nl
type
label
Histone deacetylase inhibitors promote osteoblast maturation.
@ast
Histone deacetylase inhibitors promote osteoblast maturation.
@en
Histone deacetylase inhibitors promote osteoblast maturation.
@nl
prefLabel
Histone deacetylase inhibitors promote osteoblast maturation.
@ast
Histone deacetylase inhibitors promote osteoblast maturation.
@en
Histone deacetylase inhibitors promote osteoblast maturation.
@nl
P2860
P356
P1476
Histone deacetylase inhibitors promote osteoblast maturation.
@en
P2093
Jennifer J Westendorf
Tania M Schroeder
P2860
P304
P356
10.1359/JBMR.050813
P577
2005-08-08T00:00:00Z